Report updated on 11th September, 2021: Global Human Milk Oligosaccharides Market 2021 (Includes Business Impact of COVID-19)
Global Human Milk Oligosaccharides Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights, which offers in-depth insights, revenue details, and other vital information regarding the global human milk oligosaccharides market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global human milk oligosaccharides market report has been segmented on the basis of product type, application, and region.
Request Covid - 19 Impact
The global Human Milk Oligosaccharides market size was valued at USD$102.05 million in 2020 and is projected to reach USD $857.11 million by 2030, and is anticipated to expand at a CAGR of 21.79% over the forecast period from 2020 to 2030.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the global market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the global human milk oligosaccharides market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Overview:
Human milk oligosaccharides (HMO) are part of the oligosaccharide group present in human milk. These are an unconjugated glycan complex carbohydrate and widely known as human milk glycan.
Dynamics:
The human milk oligosaccharides are widely used in livestock feeding to regulate metabolism and improve digestive system in animal infant. Therefore, growing demand for dairy products and supplements across the globe is a key factor expected to drive growth of the global human milk oligosaccharides market during the forecast period.
In addition, increasing utilization of human milk oligosaccharides in infant formula for breast-fed neonate is another factor expected to support growth of the global human milk oligosaccharides market in the near future.
Increasing concerns towards gut health among individuals across the globe resulting into rising demand for dietary supplements is expected to boost growth of the target market, owing to ability of the human milk oligosaccharides to function as soluble decoy receptors and block adhesion of microbial pathogens to epithelial surfaces.
Furthermore, changing lifestyle and increasing healthcare expenditure which in turn expected to support increasing consumption of various dietary supplements among individuals across the globe is expected to proliferate growth of the global human milk oligosaccharides market over the forecast period.
However, high cost associated with upgradation in large-scale production using advanced technology is a major factor expected to restraint growth of the target market during the forecast period. In addition, high cost associated with end product, owing to high cost associated with production process may hamper growth of the global market to a certain extent.
Segment Analysis:
On the basis of application, the infant formula segment is expected to dominate in the global human milk oligosaccharides market, owing to growing demand for human milk oligosaccharides and increasing focus on production of infant formulas for babies who are deprived of mothers milk across the globe. In addition, on the basis of application, the functional food & beverage segment is expected to register significant growth in the global market, owing to increasing utilization of global human milk oligosaccharides across the globe due to its various properties such as, high nutritional content, prebiotic properties, and ability to enhance memory and brain development.
Regional Analysis:
Market in Europe is expected to dominate in the global market, owing to high presence of leading manufactures in countries in the region. Market in Asia Pacific is projected to register high growth in terms of revenue over the next 10 years, owing to increasing demand of human milk oligosaccharides from pharmaceutical sector due to increasing awareness of various health benefits offered by unconjugated glycan among consumers in countries in this region.
The market in North America region is estimated to register lucrative growth in the global market owing to increasing demand for dietary supplements among individuals in this region. Furthermore, market in Latin America and Middle East & Africa is expected to register lucrative growth in terms of revenue, owing to increasing various initiatives by government and healthcare agencies/authorities to spread awareness about infant formula products in countries in the region.
Below are the active patents related to Human Milk Oligosaccharides Market.
Patent Number: US9283240B2
Human milk oligosaccharides for modulating inflammation
Abstract
Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
Application File Date: 2011-12-22
Application Granted Date: 2016-03-15
Current Assignee: Abbott Laboratories
Patent Number: US20120294840A1
Use Of Purified 2-Fucosyllactose, 3-Fucosyllactose and Lactodifucotetraose as Prebiotics
Abstract
The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
Application File Date: 2012-05-11
Application Granted Date: 2017-02-14
Current Assignee: Boston College Glycosyn LLC Glycosyn Trustees of Boston College LLC
Patent Number: CN104822279B
Human milk oligosaccharides for alleviating stress symptoms
Abstract
A nutritional composition comprising at least one human milk oligosaccharide selected from the group consisting of 6 -sialyllactose, lacto-N-neotetraose, lacto-N-tetraose, disialylated lacto-N-tetraose, 3 -fucosyllactose, and 3 -sialyllactose. The nutritional composition is for use in a method of reducing stress in an individual in need thereof.
Application File Date: 2013-12-18
Application Granted Date: 2020-09-11
Current Assignee: Abbott Laboratories
Global Human Milk Oligosaccharides Market Segmentation:
Segmentation by Product Type:
- 2-Fucosyllactose (2FL)
- 3-Fucosyllactose (3FL)
- 3-Sialyllactose (3SL)
- 6-Sialyllactose (6SL)
- Lacto-N-tetraose (LNT)
- Lacto-N-neotetraose (LNnT)
Segmentation by Application:
- Infant Formula
- Food Supplements
- Functional Food & Beverages
- Others (Dietary Supplements and Health ingredients for human and animal)
By Distribution Channel
- Hypermarkets & Supermarkets
- Drug Store or Pharmacy
- Mass Merchandiser
- Departmental Stores
- Mono-brand Stores
- Specialty Stores
- Online Sales Channel
Key Market Players included in the report:
- Abbott (US)
- BASF SE (Germany)
- Company two
- Dextra Laboratories Limited (UK)
- DuPont Nutrition & Health (Denmark)
- Elicityl S.A. (France)
- Glycom (Denmark)
- Glycosyn LLC (US)
- Inbiose NV (Belgium)
- Jennewein Biotechnologie GmbH (Germany)
- Medolac Laboratories (US)
- Nestlé Health Science (Switzerland)
- ZuChem (US).
Below are the key development related to Human Milk Oligosaccharides Market in 2020 and 2021.
July 2021: Adventa Bioscience® Announces Launch of Trulacta® Revolutionary supplement features natural human milk bionutrients to support adult whole-body health. Adventa Bioscience® an innovative company dedicated to improving adult human health announced the launch of Trulacta®, the worlds first and only supplement made entirely of human milk. Adventa has utilized advanced science and proprietary technology to create a supplement containing Human Milk Bionutrients™ (HMBs™), which have been shown to support whole-body health. Trulacta is composed entirely of thousands of beneficial components found in human milk, all of which are essential for health and wellbeing. The supplements HMBs include Human Milk Oligosaccharides (HMO), Growth Factors, Immunoglobulins, Macrophages and Stem Cells, as well as other enzymes and peptides critical to optimizing whole-body health. Together these rich compounds have shown to aid in the development of the immune system, protect from autoimmune disease, actively fight bacteria and allow the body to maintain and restore itself.
Source
July 2021: EIB gives 15 million euros to Ghent biotech company synthesising breast milk sugars Babies need these sugars to strengthen their immune system The European Investment Bank (EIB) will provide 15 million euros of funding to Ghent-based biotech company Inbiose. The deal was signed on 14 July and the money is part of the 540-billion-euro rescue package in response to the COVID-19 pandemic. The EIB wants to strengthen promising homegrown tech companies and Inbiose is a perfect candidate as they have found a way to imitate breast milk sugars that are not found in powdered milk. Strengthening babies’ immune systems and the European economy. At the beginning of this year, the federal government in Belgium drew up a list of projects vying for financing from the 5.95 billion euros allocated to Belgium from the European recovery fund. A significant portion of the money is invested in research and development, and this is where Inbiose comes in as one of the companies set to benefit. They are a biotech SME based in Ghent’s Zwijnaarde’s technology park and are focused on a novel production process for the synthesis of human milk oligosaccharides (HMOs), functional sugars with a wide range of applications, primarily used in infant nutrition. More than 100 different HMO structures are found in breast milk and Inbiose has found a way to produce six of them, and that is a big deal, as they are not found in powdered milk.
Source
November 2020: Kendamil unveils new Goat’s Milk Formula and announces exclusive partnership with Waitrose. Kendamil, the pioneering and uniquely British brand that is leading the way in the baby formula industry, is thrilled to unveil yet another world-first for the category. Introducing Kendamil Goat, the only British made goat formula on the market and the first of its kind to contain Human Milk Oligosaccharides (HMOs) – the third largest solid component in human breastmilk. This announcement also marks the start of an exclusive partnership with Waitrose, as Kendamil Goat will be available exclusively from the much loved retailer this November. Kendamil Goat will roll out in Waitrose stores across the country as well as being available on Waitrose Online.
Source